A citation-based method for searching scientific literature

Kai-Fan Tsai, Yung-Lung Chen, Terry Ting-Yu Chiou, Tian-Huei Chu, Lung-Chih Li, Hwee-Yeong Ng, Wen-Chin Lee, Chien-Te Lee. Antioxidants (Basel) 2021
Times Cited: 5







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
60

Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.
Carmen Hierro-Bujalance, Carmen Infante-Garcia, Angel Del Marco, Marta Herrera, Maria Jose Carranza-Naval, Javier Suarez, Pilar Alves-Martinez, Simon Lubian-Lopez, Monica Garcia-Alloza. Alzheimers Res Ther 2020
27
40



Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases.
Maddalena Grieco, Alessandra Giorgi, Maria Cristina Gentile, Maria d'Erme, Susanna Morano, Bruno Maras, Tiziana Filardi. Front Neurosci 2019
58
40

SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.
Piangkwan Sa-Nguanmoo, Pongpan Tanajak, Sasiwan Kerdphoo, Thidarat Jaiwongkam, Wasana Pratchayasakul, Nipon Chattipakorn, Siriporn C Chattipakorn. Toxicol Appl Pharmacol 2017
94
40


Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice.
Bowen Lin, Nobutaka Koibuchi, Yu Hasegawa, Daisuke Sueta, Kensuke Toyama, Ken Uekawa, MingJie Ma, Takashi Nakagawa, Hiroaki Kusaka, Shokei Kim-Mitsuyama. Cardiovasc Diabetol 2014
203
40


Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
40



In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Michael Gejl, Albert Gjedde, Lærke Egefjord, Arne Møller, Søren B Hansen, Kim Vang, Anders Rodell, Hans Brændgaard, Hanne Gottrup, Anna Schacht,[...]. Front Aging Neurosci 2016
195
20

Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus.
Yi-Chun Kuan, Kuang-Wei Huang, Cheng-Li Lin, Chaur-Jong Hu, Chia-Hung Kao. Prog Neuropsychopharmacol Biol Psychiatry 2017
70
20


A century of Alzheimer's disease.
Michel Goedert, Maria Grazia Spillantini. Science 2006
20


Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice.
Paul Millar, Nupur Pathak, Vadivel Parthsarathy, Anthony J Bjourson, Maurice O'Kane, Varun Pathak, R Charlotte Moffett, Peter R Flatt, Victor A Gault. J Endocrinol 2017
41
20

Alzheimer's disease: pathogenesis, diagnostics, and therapeutics.
Sneham Tiwari, Venkata Atluri, Ajeet Kaushik, Adriana Yndart, Madhavan Nair. Int J Nanomedicine 2019
170
20

Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.
S Craft, S Asthana, J W Newcomer, C W Wilkinson, I T Matos, L D Baker, M Cherrier, C Lofgreen, S Latendresse, A Petrova,[...]. Arch Gen Psychiatry 1999
226
20

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Suzanne Craft, Laura D Baker, Thomas J Montine, Satoshi Minoshima, G Stennis Watson, Amy Claxton, Matthew Arbuckle, Maureen Callaghan, Elaine Tsai, Stephen R Plymate,[...]. Arch Neurol 2012
809
20

Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
Mei Zhou, Shuyi Chen, Peng Peng, Zhongya Gu, Jing Yu, Gang Zhao, Yanqiu Deng. Biochem Biophys Res Commun 2019
20
20

Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.
Subbiah Pugazhenthi, Limei Qin, P Hemachandra Reddy. Biochim Biophys Acta Mol Basis Dis 2017
203
20

Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment.
Michael Gejl, Birgitte Brock, Lærke Egefjord, Kim Vang, Jørgen Rungby, Albert Gjedde. Sci Rep 2017
66
20


Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease.
Tomohiko Sato, Haruo Hanyu, Kentaro Hirao, Hidekazu Kanetaka, Hirofumi Sakurai, Toshihiko Iwamoto. Neurobiol Aging 2011
268
20

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, Gail Busza, Clive Holmes, Craig Ritchie, Robert Lawrence, Brady McFarlane, George Tadros, Basil H Ridha,[...]. Trials 2019
60
20

A GLP-1/GIP/Gcg receptor triagonist improves memory behavior, as well as synaptic transmission, neuronal excitability and Ca2+ homeostasis in 3xTg-AD mice.
Tian Li, Juan-Juan Jiao, Qiang Su, Christian Hölscher, Jun Zhang, Xu-Dong Yan, Hui-Min Zhao, Hong-Yan Cai, Jin-Shun Qi. Neuropharmacology 2020
9
20

Increased risk of cognitive impairment in patients with diabetes is associated with metformin.
Eileen M Moore, Alastair G Mander, David Ames, Mark A Kotowicz, Ross P Carne, Henry Brodaty, Michael Woodward, Karyn Boundy, Kathryn A Ellis, Ashley I Bush,[...]. Diabetes Care 2013
211
20

Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis.
A Cignarelli, F Giorgino, R Vettor. Arch Physiol Biochem 2013
15
20

Targeting the mTOR signaling network for Alzheimer's disease therapy.
Chong Wang, Jin-Tai Yu, Dan Miao, Zhong-Chen Wu, Meng-Shan Tan, Lan Tan. Mol Neurobiol 2014
71
20

Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition.
John Grizzanti, Rachel Corrigan, Gemma Casadesus. J Alzheimers Dis 2018
8
20

Regional distribution of SGLT activity in rat brain in vivo.
Amy S Yu, Bruce A Hirayama, Gerald Timbol, Jie Liu, Ana Diez-Sampedro, Vladimir Kepe, Nagichettiar Satyamurthy, Sung-Cheng Huang, Ernest M Wright, Jorge R Barrio. Am J Physiol Cell Physiol 2013
70
20

High-Fat-Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders.
Bowen Lin, Yu Hasegawa, Koki Takane, Nobutaka Koibuchi, Cheng Cao, Shokei Kim-Mitsuyama. J Am Heart Assoc 2016
52
20

Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance.
Jin-Liang Chen, Cheng Luo, Die Pu, Guo-Qiang Zhang, Yu-Xing Zhao, Yue Sun, Ke-Xiang Zhao, Zhi-Yin Liao, An-Kang Lv, Shi-Yu Zhu,[...]. Exp Neurol 2019
43
20

Sodium-glucose cotransporters: Functional properties and pharmaceutical potential.
Ryuhei Sano, Yuichi Shinozaki, Takeshi Ohta. J Diabetes Investig 2020
16
20



Insulin action in brain regulates systemic metabolism and brain function.
André Kleinridders, Heather A Ferris, Weikang Cai, C Ronald Kahn. Diabetes 2014
315
20

Associations among circulating sphingolipids, β-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China.
Huan Yun, Liang Sun, Qingqing Wu, Geng Zong, Qibin Qi, Huaixing Li, He Zheng, Rong Zeng, Liming Liang, Xu Lin. PLoS Med 2020
21
20

Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study.
Patrick Imfeld, Michael Bodmer, Susan S Jick, Christoph R Meier. J Am Geriatr Soc 2012
220
20


Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.
José A Luchsinger, Thania Perez, Helena Chang, Pankaj Mehta, Jason Steffener, Gnanavalli Pradabhan, Masanori Ichise, Jennifer Manly, Davangere P Devanand, Emilia Bagiella. J Alzheimers Dis 2016
110
20



Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs.
Angelica Artasensi, Alessandro Pedretti, Giulio Vistoli, Laura Fumagalli. Molecules 2020
43
20


Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications.
Andrea Tumminia, Federica Vinciguerra, Miriam Parisi, Lucia Frittitta. Int J Mol Sci 2018
76
20

Sphingolipids in Alzheimer's disease, how can we target them?
Simone M Crivelli, Caterina Giovagnoni, Lars Visseren, Anna-Lena Scheithauer, Nienke de Wit, Sandra den Hoedt, Mario Losen, Monique T Mulder, Jochen Walter, Helga E de Vries,[...]. Adv Drug Deliv Rev 2020
25
20

Early neonatal death in mice homozygous for a null allele of the insulin receptor gene.
D Accili, J Drago, E J Lee, M D Johnson, M H Cool, P Salvatore, L D Asico, P A José, S I Taylor, H Westphal. Nat Genet 1996
410
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.